questionsmedicales.fr
Maladies de la peau et du tissu conjonctif
Maladies de la peau
Maladies génétiques de la peau
Dysplasie ectodermique
Dysplasie ectodermique : Questions médicales fréquentes
Termes MeSH sélectionnés :
Lymphocyte Function-Associated Antigen-1
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Dysplasie ectodermique : Questions médicales les plus fréquentes",
"headline": "Dysplasie ectodermique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Dysplasie ectodermique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-13",
"dateModified": "2025-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Dysplasie ectodermique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Maladies génétiques de la peau",
"url": "https://questionsmedicales.fr/mesh/D012873",
"about": {
"@type": "MedicalCondition",
"name": "Maladies génétiques de la peau",
"code": {
"@type": "MedicalCode",
"code": "D012873",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Dysplasie ectodermique anhidrotique de type 1",
"alternateName": "Ectodermal Dysplasia 1, Anhidrotic",
"url": "https://questionsmedicales.fr/mesh/D053358",
"about": {
"@type": "MedicalCondition",
"name": "Dysplasie ectodermique anhidrotique de type 1",
"code": {
"@type": "MedicalCode",
"code": "D053358",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.198"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dysplasie ectodermique anhidrotique de type 3",
"alternateName": "Ectodermal Dysplasia 3, Anhidrotic",
"url": "https://questionsmedicales.fr/mesh/D053359",
"about": {
"@type": "MedicalCondition",
"name": "Dysplasie ectodermique anhidrotique de type 3",
"code": {
"@type": "MedicalCode",
"code": "D053359",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.298"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dysplasie ectodermique hypohidrotique autosomique récessive",
"alternateName": "Ectodermal Dysplasia, Hypohidrotic, Autosomal Recessive",
"url": "https://questionsmedicales.fr/mesh/D053360",
"about": {
"@type": "MedicalCondition",
"name": "Dysplasie ectodermique hypohidrotique autosomique récessive",
"code": {
"@type": "MedicalCode",
"code": "D053360",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.348"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndrome d'Ellis-van Creveld",
"alternateName": "Ellis-Van Creveld Syndrome",
"url": "https://questionsmedicales.fr/mesh/D004613",
"about": {
"@type": "MedicalCondition",
"name": "Syndrome d'Ellis-van Creveld",
"code": {
"@type": "MedicalCode",
"code": "D004613",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.398"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Hypoplasie dermique en aires",
"alternateName": "Focal Dermal Hypoplasia",
"url": "https://questionsmedicales.fr/mesh/D005489",
"about": {
"@type": "MedicalCondition",
"name": "Hypoplasie dermique en aires",
"code": {
"@type": "MedicalCode",
"code": "D005489",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.424"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Dysplasies dermiques faciales focales",
"alternateName": "Focal Facial Dermal Dysplasias",
"url": "https://questionsmedicales.fr/mesh/D000090303",
"about": {
"@type": "MedicalCondition",
"name": "Dysplasies dermiques faciales focales",
"code": {
"@type": "MedicalCode",
"code": "D000090303",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.568"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Syndromes neurocutanés",
"alternateName": "Neurocutaneous Syndromes",
"url": "https://questionsmedicales.fr/mesh/D020752",
"about": {
"@type": "MedicalCondition",
"name": "Syndromes neurocutanés",
"code": {
"@type": "MedicalCode",
"code": "D020752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.712"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pachyonychie congénitale",
"alternateName": "Pachyonychia Congenita",
"url": "https://questionsmedicales.fr/mesh/D053549",
"about": {
"@type": "MedicalCondition",
"name": "Pachyonychie congénitale",
"code": {
"@type": "MedicalCode",
"code": "D053549",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.856"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sébocystomatose",
"alternateName": "Steatocystoma Multiplex",
"url": "https://questionsmedicales.fr/mesh/D062685",
"about": {
"@type": "MedicalCondition",
"name": "Sébocystomatose",
"code": {
"@type": "MedicalCode",
"code": "D062685",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C17.800.827.250.856.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Dysplasie ectodermique",
"alternateName": "Ectodermal Dysplasia",
"code": {
"@type": "MedicalCode",
"code": "D004476",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Smail Hadj-Rabia",
"url": "https://questionsmedicales.fr/author/Smail%20Hadj-Rabia",
"affiliation": {
"@type": "Organization",
"name": "Department of Dermatology, Reference Center for Genodermatoses and Rare Skin Diseases (MAGEC), Filière Maladies Rares Dermatologiques (FIMARAD), ERN-Skin, Hôpital Universitaire Necker- Enfants Malades, Assistance Publique - Hôpitaux de Paris-Centre (AP-HP5), Paris, France. smail.hadj@inserm.fr."
}
},
{
"@type": "Person",
"name": "Holm Schneider",
"url": "https://questionsmedicales.fr/author/Holm%20Schneider",
"affiliation": {
"@type": "Organization",
"name": "Center for Ectodermal Dysplasias Erlangen (CEDER), University Hospital Erlangen, 91054 Erlangen, Germany."
}
},
{
"@type": "Person",
"name": "Mary Fete",
"url": "https://questionsmedicales.fr/author/Mary%20Fete",
"affiliation": {
"@type": "Organization",
"name": "National Foundation for Ectodermal Dysplasias, Fairview Heights, Illinois, USA."
}
},
{
"@type": "Person",
"name": "Feng Wang",
"url": "https://questionsmedicales.fr/author/Feng%20Wang",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Xiangdong Kong",
"url": "https://questionsmedicales.fr/author/Xiangdong%20Kong",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "An Elevated Neutrophil-to-Lymphocyte Ratio Predicts In-Hospital Mortality in Stroke Patients: A Prospective Cohort Study.",
"datePublished": "2022-11-11",
"url": "https://questionsmedicales.fr/article/36514559",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.31372"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development and initial validation of a modified lymphocyte transformation test (LTT) assay in patients with DRESS and AGEP.",
"datePublished": "2022-10-09",
"url": "https://questionsmedicales.fr/article/36210462",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s13223-022-00729-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Passenger lymphocyte syndrome after ABO-mismatched kidney transplantation: A case report and literature review.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36181973",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.trim.2022.101725"
}
},
{
"@type": "ScholarlyArticle",
"name": "Absolute lymphocyte count decreases with disease progression and is a potential prognostic marker for metastatic breast cancer.",
"datePublished": "2022-09-26",
"url": "https://questionsmedicales.fr/article/36156756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10549-022-06748-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Neutrophil-to-lymphocyte ratio is a predictor of biochemical miscarriage following artificial frozen embryo transfer cycles.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36135375",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/01443615.2022.2125296"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies de la peau et du tissu conjonctif",
"item": "https://questionsmedicales.fr/mesh/D017437"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies de la peau",
"item": "https://questionsmedicales.fr/mesh/D012871"
},
{
"@type": "ListItem",
"position": 4,
"name": "Maladies génétiques de la peau",
"item": "https://questionsmedicales.fr/mesh/D012873"
},
{
"@type": "ListItem",
"position": 5,
"name": "Dysplasie ectodermique",
"item": "https://questionsmedicales.fr/mesh/D004476"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Dysplasie ectodermique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Dysplasie ectodermique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Dysplasie ectodermique",
"description": "Comment diagnostique-t-on la dysplasie ectodermique ?\nQuels examens sont nécessaires pour le diagnostic ?\nLa biopsie est-elle utile pour le diagnostic ?\nLes antécédents familiaux sont-ils importants ?\nPeut-on diagnostiquer la dysplasie ectodermique à la naissance ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Dysplasie ectodermique",
"description": "Quels sont les symptômes courants de la dysplasie ectodermique ?\nLa dysplasie ectodermique affecte-t-elle la dentition ?\nY a-t-il des problèmes de peau associés ?\nLes personnes atteintes ont-elles des problèmes de chaleur ?\nLes symptômes varient-ils d'une personne à l'autre ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Dysplasie ectodermique",
"description": "Peut-on prévenir la dysplasie ectodermique ?\nLe conseil génétique est-il recommandé ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nLes femmes enceintes doivent-elles être informées ?\nY a-t-il des mesures préventives pour les enfants ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Dysplasie ectodermique",
"description": "Quels traitements sont disponibles pour la dysplasie ectodermique ?\nLa chirurgie est-elle une option de traitement ?\nY a-t-il des traitements pour améliorer la sudation ?\nLes traitements sont-ils personnalisés ?\nLes traitements peuvent-ils améliorer la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Dysplasie ectodermique",
"description": "Quelles complications peuvent survenir avec la dysplasie ectodermique ?\nLes infections sont-elles fréquentes ?\nY a-t-il des complications psychologiques ?\nLes problèmes dentaires peuvent-ils causer des douleurs ?\nLes troubles thermiques peuvent-ils être graves ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Dysplasie ectodermique",
"description": "Quels sont les facteurs de risque de la dysplasie ectodermique ?\nLa consanguinité augmente-t-elle le risque ?\nLes hommes sont-ils plus touchés que les femmes ?\nLes facteurs environnementaux jouent-ils un rôle ?\nLes mutations génétiques sont-elles héréditaires ?",
"url": "https://questionsmedicales.fr/mesh/D004476?mesh_terms=Lymphocyte+Function-Associated+Antigen-1&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la dysplasie ectodermique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique et des tests génétiques pour identifier les mutations."
}
},
{
"@type": "Question",
"name": "Quels examens sont nécessaires pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens cliniques, des analyses de sang et des tests d'imagerie peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "La biopsie est-elle utile pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une biopsie cutanée peut aider à évaluer les anomalies ectodermiques."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux sont-ils importants ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique à la maladie."
}
},
{
"@type": "Question",
"name": "Peut-on diagnostiquer la dysplasie ectodermique à la naissance ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains signes peuvent être visibles à la naissance, facilitant le diagnostic précoce."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants de la dysplasie ectodermique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des anomalies dentaires, des cheveux clairsemés et une sudation réduite."
}
},
{
"@type": "Question",
"name": "La dysplasie ectodermique affecte-t-elle la dentition ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut entraîner des dents manquantes, malformées ou en nombre réduit."
}
},
{
"@type": "Question",
"name": "Y a-t-il des problèmes de peau associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies cutanées comme une peau sèche ou des éruptions peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les personnes atteintes ont-elles des problèmes de chaleur ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la réduction de la sudation peut entraîner des difficultés à réguler la température corporelle."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils d'une personne à l'autre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'expression des symptômes peut varier considérablement selon les individus."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la dysplasie ectodermique ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Étant une maladie génétique, il n'existe pas de méthode de prévention connue."
}
},
{
"@type": "Question",
"name": "Le conseil génétique est-il recommandé ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le conseil génétique peut aider les familles à comprendre les risques de transmission."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests peuvent identifier les porteurs de mutations et informer les décisions familiales."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes doivent-elles être informées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes avec des antécédents familiaux devraient être informées des risques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les enfants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Bien qu'il n'y ait pas de prévention, un suivi médical régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour la dysplasie ectodermique ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des soins dentaires, des thérapies pour la peau et des prothèses capillaires."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle une option de traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des interventions chirurgicales peuvent être nécessaires pour corriger des anomalies dentaires."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements pour améliorer la sudation ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements comme l'hydratation et des vêtements adaptés peuvent aider à gérer la chaleur."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils personnalisés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements sont souvent adaptés aux besoins spécifiques de chaque patient."
}
},
{
"@type": "Question",
"name": "Les traitements peuvent-ils améliorer la qualité de vie ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un traitement approprié peut significativement améliorer la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec la dysplasie ectodermique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections cutanées, des problèmes dentaires et des troubles thermiques."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles fréquentes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la peau sèche et les anomalies peuvent augmenter le risque d'infections cutanées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des complications psychologiques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les problèmes d'apparence peuvent entraîner des troubles de l'estime de soi et de l'anxiété."
}
},
{
"@type": "Question",
"name": "Les problèmes dentaires peuvent-ils causer des douleurs ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anomalies dentaires peuvent entraîner des douleurs et des difficultés à mastiquer."
}
},
{
"@type": "Question",
"name": "Les troubles thermiques peuvent-ils être graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles thermiques peuvent entraîner des coups de chaleur dans des conditions extrêmes."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de la dysplasie ectodermique ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs de risque incluent des antécédents familiaux et des mutations génétiques spécifiques."
}
},
{
"@type": "Question",
"name": "La consanguinité augmente-t-elle le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la consanguinité peut augmenter la probabilité de transmission de mutations génétiques."
}
},
{
"@type": "Question",
"name": "Les hommes sont-ils plus touchés que les femmes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines formes de dysplasie ectodermique sont plus fréquentes chez les hommes."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la dysplasie ectodermique est principalement causée par des facteurs génétiques."
}
},
{
"@type": "Question",
"name": "Les mutations génétiques sont-elles héréditaires ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la plupart des cas de dysplasie ectodermique sont héréditaires et suivent un mode de transmission spécifique."
}
}
]
}
]
}
Introduction Cerebrovascular accidents or strokes are a major cause of mortality and morbidity in today's world. Post-stroke disabilities like paralysis, dementia, etc., can affect the quality of life...
The lymphocyte transformation test (LTT) is an in vitro assay used to diagnose drug induced hypersensitivity reactions by detecting the activation and expansion of drug-specific memory T cells to the ...
To examine safe alternatives to 3H-thymidine, test assay modifications for improved assay sensitivity and evaluate the modified LTT in patients with DRESS and AGEP....
Four proliferation detection assays (BRDU, CyQUANT™, MTT and XTT) were screened for LTT sensitivity. XTT the most sensitive and practical was selected for further evaluation Modifications like autolog...
Of the non-radioactive alternatives we tested, XTT a colorimetric assay was the most sensitive and practical to move to evaluation. The addition of AS increased background signal. Depletion of T-REGs ...
XTT appears to be a safe, viable alternative to 3H-thymidine, with high sensitivity and allowing direct cytokine quantification on specific patient cells....
Passenger lymphocyte syndrome (PLS) is a rare post solid organ transplantation complication, usually occurring after ABO- or Rh-mismatched transplantation. In general, PLS can lead to severe hemolytic...
In our case, the allograft was given by an O-type Rh-D(+) donor and received by an A-type Rh-D(+) recipient. The PLS was developed on the post-operative day (POD) 10 with an increased indirect bilirub...
In ABO-mismatched kidney transplantation, an increased level of IDBIL should be considered as the first symptom of PLS even without an Hb decrease. The kidney function may be not affected by the PLS s...
Peripheral blood parameters such as the neutrophil-to-lymphocyte ratio (NLR) are prognostic markers for breast cancer patients. For instance, patients with a high NLR have a poor prognosis. Meanwhile,...
We retrospectively investigated 156 patients who were treated for MBC and eventually transitioned to best supportive care (BSC) at our hospital between January 2017 and December 2021. Changes in perip...
From the time of MBC diagnosis (baseline) through to the transition to BSC, ALC became significantly lower, while the NLR and platelet-to-lymphocyte ratio (PLR) became significantly higher (p < 0.001 ...
We observed that peripheral blood markers gradually changed with MBC disease progression. Our data suggest that baseline ALC may be a potential prognostic marker after recurrence....
The aim of this study is to examine the relationship between complete blood count (CBC) inflammatory markers and pregnancy outcome following artificial frozen embryo transfer cycles (AC-FET). This was...
Currently, the relationship between radiation pneumonia (RP) and circulating immune cell in patients with esophageal squamous cell carcinoma (ESCC) remains unclear. This study aimed to explore the rel...
This study retrospectively included 121 patients with ESCC receiving CRT from Guangxi Medical University Cancer Hospital from 2013 to 2021. Independent factors associated with occurrence of RP and ≥ g...
Multivariate analysis suggested that TNM stage, post-RT percentage of CD8+ T cell, and lung V15 were independent predictive factors of RP. Besides, pre- and post-RT percentage of CD8+ T cell, and V15 ...
TNM stage, post-RT percentage of CD8+ T cell, and lung V15 were the independent predictors of RP toxicity. Pre- and post-RT percentage of CD8+ T cell, and lung V15 were the independent factors of ≥ gr...
Lymphocytes regulate the immune response by circulating between the vascular and lymphatic systems. High endothelial venules, HEVs, special blood vessels expressing selective adhesion molecules, such ...
This study was performed to determine the prognostic value of lymphocyte-to-CRP ratio after curative resection for hepatocellular carcinoma....
Between July 2010 and October 2021, 173 consecutive patients (144 male, 29 female) who underwent surgical resection for pathologically confirmed hepatocellular carcinoma were included in this retrospe...
The patients (mean age, 71 years) were stratified into high (≥9,500, n = 108) and low (<9,500, n = 65) lymphocyte-to-CRP ratio groups. The low lymphocyte-to-CRP ratio group had significantly worse RFS...
Lymphocyte-to-CRP ratio is superior to other inflammation-based markers as a predictor of RFS in patients with surgically resected hepatocellular carcinoma....
We previously observed an increase of serum interleukins (IL) and a reduction of most lymphocyte subpopulations in hospitalized COVID-19 patients. Herein, we aimed to evaluate the changes in serum IL-...
The burden of COVID-19 remains unchanged for immunocompromised patients who do not respond to vaccines. Unfortunately, Omicron sublineages are resistant to monoclonal antibodies authorized in Europe s...